Please wait a minute...
浙江大学学报(医学版)  2016, Vol. 45 Issue (1): 98-101    DOI: 10.3785/j.issn.1008-9292.2016.01.16
会议亮点     
非酒精性脂肪性肝病研究前沿
施军平
杭州师范大学附属医院肝病科, 浙江 杭州 310015
Frontiers of research on nonalcoholic fatty liver disease
SHI Junping
Department of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
全文: PDF(801 KB)  
关键词 脂肪肝/病理学肝疾病代谢综合征X前瞻性研究    
Key wordsFatty liver/pathology    Liver diseases    Metabolic syndrome X    Prospective studies
收稿日期: 2015-12-03      出版日期: 2015-12-12
CLC:  R575  
基金资助:

国家自然科学基金(81570524);浙江省自然科学基金(LY15H070004,LY14H070004)

通讯作者: 施军平(1970-),男,博士,主任医师,教授,博士生导师,主要从事脂肪肝和酒精肝的临床与基础研究;E-mail:13957121199@vip.126.com;http://orcid.org//0000-0002-1356-4994     E-mail: 13957121199@vip.126.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
施军平

引用本文:

施军平. 非酒精性脂肪性肝病研究前沿[J]. 浙江大学学报(医学版), 2016, 45(1): 98-101.
SHI Junping. Frontiers of research on nonalcoholic fatty liver disease. Journal of ZheJiang University(Medical Science), 2016, 45(1): 98-101.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2016.01.16      或      http://www.zjujournals.com/xueshu/med/CN/Y2016/V45/I1/98

[1] RINELLA M E. Nonalcoholic fatty liver disease:a systematic review[J]. JAMA, 2015, 313(22):2263-2273.
[2] KARIM M F, AL-MAHTAB M, RAHMAN S, et al. Nonalcoholic fatty liver disease (NAFLD)-a review[J]. Mymensingh Med J, 2015, 24(4):873-880.
[3] MCPHERSON S, HARDY T, HENDERSON E, et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies:implications for prognosis and clinical management[J]. J Hepatol, 2015, 62(5):1148-1155.
[4] ADAMS L A, SANDERSON S, LINDOR K D, et al. The histological course of nonalcoholic fatty liver disease:a longitudinal study of 103 patients with sequential liver biopsies[J]. J Hepatol, 2005, 42(1):132-138.
[5] DATZ C, FELDER T K, NIEDERSEER D, et al. Iron homeostasis in the metabolic syndrome[J]. Eur J Clin Invest, 2013, 43(2):215-224.
[6] BESTE L A, LEIPERTZ S L, GREEN P K, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013[J]. Gastroenterology, 2015,149(6):1471-1482.
[7] YOPP A C, CHOTI M A. Nonalcoholic steatohepatitis-related hepatocellular carcinoma:a growing epidemic?[J]. Dig Dis, 2015, 33(5):642-647.
[8] TORRES D M, HARRISON S A. Nonalcoholic fatty liver disease:fibrosis portends a worse prognosis[J]. Hepatology, 2015,61(5):1462-1464.
[9] ANGULO P, HUI J M, MARCHESINI G, et al. The NAFLD fibrosis score:a noninvasive system that identifies liver fibrosis in patients with NAFLD[J]. Hepatology, 2007, 45(4):846-854.
[10] FEDCHUK L, NASCIMBENI F, PAIS R, et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2014, 40(10):1209-1222.
[11] GORDEN D L, MYERS D S, IVANOVA P T, et al. Biomarkers of NAFLD progression:a lipidomics approach to an epidemic[J]. J Lipid Res, 2015, 56(3):722-736.
[12] BELL L N, WANG J, MURALIDHARAN S, et al. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis:a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study[J]. Hepatology, 2012, 56(4):1311-1318.
[13] VERBEEK J, LANNOO M, PIRINEN E, et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with nonalcoholic steatohepatitis[J]. Gut, 2015, 64(4):673-683.
[14] LASSAILLY G, CAIAZZO R, BUOB D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients[J]. Gastroenterology, 2015, 149(2):379-388.
[15] GANZ M, SZABO G. Immune and inflammatory pathways in NASH[J]. Hepatol Int, 2013, 7(Suppl 2):S771-S781.
[16] MIELE L, MARRONE G, LAURITANO C, et al. Gut-liver axis and microbiota in NAFLD:insight pathophysiology for novel therapeutic target[J]. Curr Pharm Des, 2013, 19(29):5314-5324.
[1] 姚美芳 等. 2型糖尿病患者合并代谢综合征增加Framingham心血管危险评分[J]. 浙江大学学报(医学版), 2016, 45(3): 268-274.
[2] 王悠清, 叶丁, 李迎君, 陈坤. 亚洲地区成人体质量指数与全因死亡率关系的meta分析[J]. 浙江大学学报(医学版), 2015, 44(2): 189-196.
[3] 金文媛, 赵正言. 低密度脂蛋白受体与代谢综合征的相关性研究进展[J]. 浙江大学学报(医学版), 2015, 44(1): 101-107.
[4] 吴大兴,吴丽峰,杨宗兴. 雄激素性脱发与代谢综合征关系的meta分析[J]. 浙江大学学报(医学版), 2014, 43(5): 597-.
[5] 张晓勤,蒲虹,王艺萍,等. 血浆凝溶胶蛋白水平在危重症患者预后评估中的应用[J]. 浙江大学学报(医学版), 2014, 43(5): 541-.
[6] 林胡,傅君芬,陈雪峰,黄轲,吴蔚,梁黎. 肥胖儿童青少年非酒精性脂肪肝病早期肾功能状况研究[J]. 浙江大学学报(医学版), 2013, 42(4): 381-.
[7] 陈联辉,梁黎,傅君芬,朱伟芬,王春林,黄轲,方燕兰,陈雪峰. 两种儿童青少年代谢综合征定义的临床应用比较[J]. 浙江大学学报(医学版), 2013, 42(4): 375-.
[8] 陈燕,蒋天安,敖建阳,黄敏,陈芬,赵齐羽. 超声造影在肝脏炎性假瘤诊断中的临床价值探讨[J]. 浙江大学学报(医学版), 2010, 39(6): 634-637+656.
[9] 赵四海;楚雍烈;刘恩岐. 角蛋白8在四氯化碳诱导的小鼠肝损伤中的表达[J]. 浙江大学学报(医学版), 2010, 39(1): 37-42.
[10] 刘鸿明;赖灿;章士正. 磁共振DTT成像对急性腔隙性脑梗死患者运动功能预后评估的价值[J]. 浙江大学学报(医学版), 2009, 38(2): 186-193.
[11] 李军;丁克峰;王晓晨;孙立峰;王建伟;张苏展. 腹腔镜手术后直肠癌患者生活质量评价[J]. 浙江大学学报(医学版), 2007, 36(4): 371-377.
[12] 孙雅逊%胡申江%张新华%孙坚%朱朝辉%张志杰. 代谢综合征及其代谢指标异常对患者血浆vWF与NO含量的影响[J]. 浙江大学学报(医学版), 2006, 35(3): 315-318.
[13] 郑芹珠;王立明;楼宜嘉. 卡介苗联合脂多糖诱发大鼠原代培养肝细胞免疫性损伤模型的构建[J]. 浙江大学学报(医学版), 2002, 31(6): 419-423.